Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GPG Ventures

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 3
Lead investments 0
Exits 1
Key employees 2

Areas of investment

  • Therapeutics
  • Artificial Intelligence
  • Biotechnology
  • Pharmaceutical
  • Computer
Summary

Among the most popular portfolio startups of the fund, we may highlight Hypergiant Sensory Sciences, Lantern Pharma. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Alternative Medicine, Pharmaceutical.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the GPG Ventures, startups are often financed by Health Wildcatters, Green Park & Golf Ventures. The meaningful sponsors for the fund in investment in the same round are Chris Rhodes, Capital Factory, Bios Partners.

Besides them, we counted 1 critical employee of this fund in our database.

The important activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GPG Ventures:
Typical Co-investors
GPG Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GPG Ventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
360ip Japan Japan, Tokyo
AAVCF -
Beijing Phoenix Wealth Holding Group -
Berkeley Ventures Berkeley, California, United States
BP Marsh & Partners England, London, United Kingdom
Caivis District of Columbia, United States, Washington
Chalor Capital -
Cleveland Avenue Chicago, Illinois, United States
Deveaux Group Aquitaine, France, New Aquitaine
Fort Point Angels Boston, Massachusetts, United States
Guangjin Touzi China, Guangdong, Guangzhou
Hatch Ventures Redmond, United States, Washington
Hillsborough Venture -
Hinduja Group India, Maharashtra, Mumbai
iKang Healthcare Group Beijing, Beijing, China
IndustryClick New Jersey, Princeton, United States
Lichengbei Chuangtou China, Qingdao Shi, Shandong
Linic Ltd -
Marcus & Millichap Calabasas, California, United States
Parliament Capital Management -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Iterion Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$17M16 Feb 2021 Houston, Texas, United States

Hypergiant Sensory Sciences

Artificial Intelligence
Computer
Software
$5M30 Nov 2018 Dallas, Texas, United States

Lantern Pharma

Artificial Intelligence
Biotechnology
Pharmaceutical
Therapeutics
$3M02 May 2017 Dallas, Texas, United States
News
Iterion Therapeutics Lands $17M Series B

– Iterion Therapeutics, a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, has raised $17m in a Series B financing.
РThe round was led by Lumira Ventures, with the participation of existing investors, including Sant̩ Ventures, as well as new investors Venture Investors, GPG Ventures, and Viva BioInnovator.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GPG Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: